2020
DOI: 10.1007/978-1-0716-0849-4_7
|View full text |Cite
|
Sign up to set email alerts
|

Challenges and Opportunities of Genomic Approaches in Therapeutics Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 200 publications
0
1
0
Order By: Relevance
“…Genome-Wide Association Studies (GWAS) seek to identify genetic variants that have a statistically significant association to a trait, such as a disease or other phenotype of interest. GWAS has been widely employed towards a large variety of objectives, including genetic epidemiology, precision medicine, polygenic risk scores, therapeutic development, network-based and machine learning approaches [1][2][3][4][5][6] . A rapid explosion in the quantity of genomic data has created the need for systematic, standardised, and reproducible quality control (QC).…”
Section: Introductionmentioning
confidence: 99%
“…Genome-Wide Association Studies (GWAS) seek to identify genetic variants that have a statistically significant association to a trait, such as a disease or other phenotype of interest. GWAS has been widely employed towards a large variety of objectives, including genetic epidemiology, precision medicine, polygenic risk scores, therapeutic development, network-based and machine learning approaches [1][2][3][4][5][6] . A rapid explosion in the quantity of genomic data has created the need for systematic, standardised, and reproducible quality control (QC).…”
Section: Introductionmentioning
confidence: 99%